Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Burke Internal Medicine And Research
mi
from
Burke, VA
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Burke Internal Medicine And Research
mi
from
Burke, VA
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Manassas Clinical Research Center
mi
from
Manassas, VA
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Manassas Clinical Research Center
mi
from
Manassas, VA
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Clinical Research Partners
mi
from
Richmond, VA
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Clinical Research Partners
mi
from
Richmond, VA
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Universal Research Group
mi
from
Tacoma, WA
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Universal Research Group
mi
from
Tacoma, WA
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Puerto Rico Renal and Health Research, Inc.
mi
from
Carolina,
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Puerto Rico Renal and Health Research, Inc.
mi
from
Carolina,
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Consano Clinical Research
mi
from
Shavano Park, TX
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Consano Clinical Research
mi
from
Shavano Park, TX
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Terence T. Hart, MD
mi
from
Tuscumbia, AL
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Terence T. Hart, MD
mi
from
Tuscumbia, AL
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Catalina Research Institute, LLC
mi
from
Montclair, CA
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Catalina Research Institute, LLC
mi
from
Montclair, CA
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Infosphere Clinical Research
mi
from
Van Nuys, CA
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Infosphere Clinical Research
mi
from
Van Nuys, CA
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Meridien Reserach - St. Petersburg
mi
from
Saint Petersburg, FL
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Meridien Reserach - St. Petersburg
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Brandywine Clinical Research
mi
from
Downingtown, PA
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Brandywine Clinical Research
mi
from
Downingtown, PA
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
PMG of Charleston, LLC
mi
from
Mount Pleasant, SC
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
PMG of Charleston, LLC
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Southwest Health Associates, P.A.
mi
from
Sugar Land, TX
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Southwest Health Associates, P.A.
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Chrysalis Clinical Research
mi
from
Saint George, UT
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Chrysalis Clinical Research
mi
from
Saint George, UT
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Medical Group Of Encino
mi
from
Encino, CA
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Medical Group Of Encino
mi
from
Encino, CA
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
National Research Institute
mi
from
Huntington Park, CA
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
National Research Institute
mi
from
Huntington Park, CA
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
National Research Institute
mi
from
Los Angeles, CA
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
New Horizon Research Center
mi
from
Miami, FL
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
New Horizon Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Metabolic Research Institute, Inc.
mi
from
West Palm Beach, FL
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Metabolic Research Institute, Inc.
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Cotton O'Neil Diabetes and Endocrinology Center
mi
from
Topeka, KA
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Cotton O'Neil Diabetes and Endocrinology Center
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
JCMG Clinical Research
mi
from
Jefferson City, MO
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
JCMG Clinical Research
mi
from
Jefferson City, MO
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Grand Street Medical PC
mi
from
Brooklyn, NY
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Grand Street Medical PC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
PMG Research of Wilmington
mi
from
Wilmington, NC
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Galenos Research
mi
from
Dallas, TX
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Galenos Research
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/27/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Saint Stefan Ob Stainz,
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/27/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Saint Stefan Ob Stainz,
Click here to add this to my saved trials
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States - Additional Analyses
Status: Enrolling
Updated:  3/27/2018
Optum Epidemiology
mi
from
Boston, MA
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States - Additional Analyses
Status: Enrolling
Updated: 3/27/2018
Optum Epidemiology
mi
from
Boston, MA
Click here to add this to my saved trials
Preferred Treatment of Type 1.5 Diabetes
Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes
Status: Enrolling
Updated:  3/27/2018
DVA Puget Sound Health Care System
mi
from
Seattle, WA
Preferred Treatment of Type 1.5 Diabetes
Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes
Status: Enrolling
Updated: 3/27/2018
DVA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Primary Care Community Partnerships to Prevent Diabetes
Primary Care Community Partnerships to Prevent Diabetes
Status: Enrolling
Updated:  3/27/2018
Northwestern University
mi
from
Chicago, IL
Primary Care Community Partnerships to Prevent Diabetes
Primary Care Community Partnerships to Prevent Diabetes
Status: Enrolling
Updated: 3/27/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study
Community Translation of a Lifestyle Intervention to Improve Health in Diabetes
Status: Enrolling
Updated:  3/27/2018
YMCA of Metro Chicago
mi
from
Chicago, IL
Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study
Community Translation of a Lifestyle Intervention to Improve Health in Diabetes
Status: Enrolling
Updated: 3/27/2018
YMCA of Metro Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study
Community Translation of a Lifestyle Intervention to Improve Health in Diabetes
Status: Enrolling
Updated:  3/27/2018
McGaw YMCA
mi
from
Evanston, IL
Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study
Community Translation of a Lifestyle Intervention to Improve Health in Diabetes
Status: Enrolling
Updated: 3/27/2018
McGaw YMCA
mi
from
Evanston, IL
Click here to add this to my saved trials
Group vs. Traditional Diabetes Prenatal Care
Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.
Status: Enrolling
Updated:  3/28/2018
UnityPoint Health-Meriter Hospital
mi
from
Madison, WI
Group vs. Traditional Diabetes Prenatal Care
Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.
Status: Enrolling
Updated: 3/28/2018
UnityPoint Health-Meriter Hospital
mi
from
Madison, WI
Click here to add this to my saved trials
Vascular Risk Progression in Normal and Diabetic Control Subjects.
Vascular Risk Progression in Normal and Diabetes Control Subjects
Status: Enrolling
Updated:  3/29/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Vascular Risk Progression in Normal and Diabetic Control Subjects.
Vascular Risk Progression in Normal and Diabetes Control Subjects
Status: Enrolling
Updated: 3/29/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Ghrelin and Beta Cell Function in Diabetes
Ghrelin Effect on Beta Cell Function in Health and Disease #2
Status: Enrolling
Updated:  3/29/2018
Duke Center For Living
mi
from
Durham, NC
Ghrelin and Beta Cell Function in Diabetes
Ghrelin Effect on Beta Cell Function in Health and Disease #2
Status: Enrolling
Updated: 3/29/2018
Duke Center For Living
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.
A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Multiple Dose Study to Assess the Safety and Tolerability of ASP1941 in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/29/2018
Clinical Research Facility
mi
from
San Antonio, TX
A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.
A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Multiple Dose Study to Assess the Safety and Tolerability of ASP1941 in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/29/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
Status: Enrolling
Updated:  3/30/2018
University of Florida Department of Community Health and Family Medicine
mi
from
Gainesville, FL
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
Status: Enrolling
Updated: 3/30/2018
University of Florida Department of Community Health and Family Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
Status: Enrolling
Updated:  4/2/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
Status: Enrolling
Updated: 4/2/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Fat Grafting for Pedal Fat Pad Atrophy in Diabetics
Fat Grafting for Pedal Fat Pad Atrophy in Diabetics
Status: Enrolling
Updated:  4/2/2018
University of Pittsburgh Department of Plastic Medicine
mi
from
Pittsburgh, PA
Fat Grafting for Pedal Fat Pad Atrophy in Diabetics
Fat Grafting for Pedal Fat Pad Atrophy in Diabetics
Status: Enrolling
Updated: 4/2/2018
University of Pittsburgh Department of Plastic Medicine
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes
Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes (Triabetes) - Alliance of Randomized Trials of Medicine vs. Metabolic Surgery in Type 2 Diabetes ARMMST2D)
Status: Enrolling
Updated:  4/3/2018
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes
Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes (Triabetes) - Alliance of Randomized Trials of Medicine vs. Metabolic Surgery in Type 2 Diabetes ARMMST2D)
Status: Enrolling
Updated: 4/3/2018
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Boosting Emotions & Happiness in Outpatients Living With Diabetes: Phase I
A Novel Psychological-behavioral Intervention to Improve Activity in Type 2 Diabetes: Proof-of-concept Trial
Status: Enrolling
Updated:  4/3/2018
Massachusetts General Hospital
mi
from
Boston, MA
Boosting Emotions & Happiness in Outpatients Living With Diabetes: Phase I
A Novel Psychological-behavioral Intervention to Improve Activity in Type 2 Diabetes: Proof-of-concept Trial
Status: Enrolling
Updated: 4/3/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Development of Self-Regulation in Individuals With Type 2 Diabetes
Status: Enrolling
Updated:  4/3/2018
University of Tennessee, Healthy Eating and Activity Laboratory (HEAL)
mi
from
Knoxville, TN
Development of Self-Regulation in Individuals With Type 2 Diabetes
Status: Enrolling
Updated: 4/3/2018
University of Tennessee, Healthy Eating and Activity Laboratory (HEAL)
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Study of the Function of Hormones Present In Taste Buds
A Study of the Function of Hormones Present In Taste Buds
Status: Enrolling
Updated:  4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
A Study of the Function of Hormones Present In Taste Buds
A Study of the Function of Hormones Present In Taste Buds
Status: Enrolling
Updated: 4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
CARDIA Brain MRI Substudy
Contribution of Diabetes and Its Causes to Signs of Brain Aging in a Young-to-Middle Age Cohort
Status: Enrolling
Updated:  4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
CARDIA Brain MRI Substudy
Contribution of Diabetes and Its Causes to Signs of Brain Aging in a Young-to-Middle Age Cohort
Status: Enrolling
Updated: 4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Diabetes PRP and OCT
Pilot Study OCT of Retinal Blood Flow in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation
Status: Enrolling
Updated:  4/5/2018
Oregon Health and Science University
mi
from
Portland, OR
Diabetes PRP and OCT
Pilot Study OCT of Retinal Blood Flow in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation
Status: Enrolling
Updated: 4/5/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Diabetes Self-Management & Support LIVE
Diabetes Self-Management & Support LIVE (Learning in Virtual Environments)
Status: Enrolling
Updated:  4/5/2018
New York University
mi
from
New York, NY
Diabetes Self-Management & Support LIVE
Diabetes Self-Management & Support LIVE (Learning in Virtual Environments)
Status: Enrolling
Updated: 4/5/2018
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Diabetes Self-Management & Support LIVE
Diabetes Self-Management & Support LIVE (Learning in Virtual Environments)
Status: Enrolling
Updated:  4/5/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Diabetes Self-Management & Support LIVE
Diabetes Self-Management & Support LIVE (Learning in Virtual Environments)
Status: Enrolling
Updated: 4/5/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
Phase 2a Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  4/6/2018
Pinnacle Research Group, LLC
mi
from
Anniston, AL
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
Phase 2a Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 4/6/2018
Pinnacle Research Group, LLC
mi
from
Anniston, AL
Click here to add this to my saved trials
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
Phase 2a Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  4/6/2018
National Research Institute
mi
from
Huntington Park, CA
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
Phase 2a Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 4/6/2018
National Research Institute
mi
from
Huntington Park, CA
Click here to add this to my saved trials